Publication: Comment on: Planned dose of intensity modulated proton beam therapy versus volumetric modulated arch therapy to tooth-bearing regions
| dc.contributor.author | Yilmaz, Busra | |
| dc.contributor.author | Topkan, Erkan | |
| dc.contributor.institution | Yilmaz, Busra, Department of Oral and Maxillofacial Surgery, Bahçeşehir Üniversitesi, Istanbul, Turkey | |
| dc.contributor.institution | Topkan, Erkan, Department of Radiation Oncology, Başkent Üniversitesi, Ankara, Turkey | |
| dc.date.accessioned | 2025-10-05T15:02:29Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | [No abstract available] | |
| dc.identifier.doi | 10.1016/j.oraloncology.2023.106418 | |
| dc.identifier.issn | 18790593 | |
| dc.identifier.issn | 13688375 | |
| dc.identifier.pubmed | 37163790 | |
| dc.identifier.scopus | 2-s2.0-85156194902 | |
| dc.identifier.uri | https://doi.org/10.1016/j.oraloncology.2023.106418 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14719/7948 | |
| dc.identifier.volume | 142 | |
| dc.language.iso | en | |
| dc.publisher | Elsevier Ltd | |
| dc.relation.source | Oral Oncology | |
| dc.subject.authorkeywords | Carmustine | |
| dc.subject.authorkeywords | Etoposide | |
| dc.subject.authorkeywords | Carmustine | |
| dc.subject.authorkeywords | Etoposide | |
| dc.subject.authorkeywords | Cancer Staging | |
| dc.subject.authorkeywords | Clinical Outcome | |
| dc.subject.authorkeywords | Comparative Study | |
| dc.subject.authorkeywords | Head And Neck Cancer | |
| dc.subject.authorkeywords | Human | |
| dc.subject.authorkeywords | Intensity Modulated Radiation Therapy | |
| dc.subject.authorkeywords | Letter | |
| dc.subject.authorkeywords | Osteoradionecrosis | |
| dc.subject.authorkeywords | Proton Therapy | |
| dc.subject.authorkeywords | Radiation Dose | |
| dc.subject.authorkeywords | Tooth | |
| dc.subject.authorkeywords | Tooth Extraction | |
| dc.subject.authorkeywords | Volumetric Modulated Arc Therapy | |
| dc.subject.authorkeywords | Radiotherapy Dosage | |
| dc.subject.authorkeywords | Carmustine | |
| dc.subject.authorkeywords | Etoposide | |
| dc.subject.authorkeywords | Carmustine | |
| dc.subject.authorkeywords | Etoposide | |
| dc.subject.authorkeywords | Humans | |
| dc.subject.authorkeywords | Proton Therapy | |
| dc.subject.authorkeywords | Radiotherapy Dosage | |
| dc.subject.authorkeywords | Radiotherapy Planning, Computer-assisted | |
| dc.subject.authorkeywords | Radiotherapy, Intensity-modulated | |
| dc.subject.indexkeywords | cancer staging | |
| dc.subject.indexkeywords | clinical outcome | |
| dc.subject.indexkeywords | comparative study | |
| dc.subject.indexkeywords | head and neck cancer | |
| dc.subject.indexkeywords | human | |
| dc.subject.indexkeywords | intensity modulated radiation therapy | |
| dc.subject.indexkeywords | Letter | |
| dc.subject.indexkeywords | osteoradionecrosis | |
| dc.subject.indexkeywords | proton therapy | |
| dc.subject.indexkeywords | radiation dose | |
| dc.subject.indexkeywords | tooth | |
| dc.subject.indexkeywords | tooth extraction | |
| dc.subject.indexkeywords | volumetric modulated arc therapy | |
| dc.subject.indexkeywords | radiotherapy dosage | |
| dc.subject.indexkeywords | carmustine | |
| dc.subject.indexkeywords | etoposide | |
| dc.subject.indexkeywords | Carmustine | |
| dc.subject.indexkeywords | Etoposide | |
| dc.subject.indexkeywords | Humans | |
| dc.subject.indexkeywords | Proton Therapy | |
| dc.subject.indexkeywords | Radiotherapy Dosage | |
| dc.subject.indexkeywords | Radiotherapy Planning, Computer-Assisted | |
| dc.subject.indexkeywords | Radiotherapy, Intensity-Modulated | |
| dc.title | Comment on: Planned dose of intensity modulated proton beam therapy versus volumetric modulated arch therapy to tooth-bearing regions | |
| dc.type | Letter | |
| dcterms.references | Alberga, Jamie M., Planned dose of intensity modulated proton beam therapy versus volumetric modulated arch therapy to tooth-bearing regions, Oral Oncology, 140, (2023), Taylor, Jeremy M.G., Dose, time, and fraction size issues for late effects in head and neck cancers, International Journal of Radiation Oncology Biology Physics, 22, 1, pp. 3-11, (1992), Moon, Dominic H., Incidence of, and risk factors for, mandibular osteoradionecrosis in patients with oral cavity and oropharynx cancers, Oral Oncology, 72, pp. 98-103, (2017), Singh, Annu, Osteoradionecrosis of the Jaw Following Proton Radiation Therapy for Patients With Head and Neck Cancer, JAMA Otolaryngology - Head and Neck Surgery, 149, 2, pp. 151-159, (2023), Yilmaz, Busra, The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy, BMC Oral Health, 23, 1, (2023), Frankart, Andrew J., Osteoradionecrosis: Exposing the Evidence Not the Bone, International Journal of Radiation Oncology Biology Physics, 109, 5, pp. 1206-1218, (2021) | |
| dspace.entity.type | Publication | |
| local.indexed.at | Scopus | |
| person.identifier.scopus-author-id | 57190382171 | |
| person.identifier.scopus-author-id | 55885460400 |
